A common side effect of GLP-1 therapy is that you feel full sooner and reduce appetite , which can change how your body responds to an alcoholic beverage
Our core values guide everything we do, including standards that ensure the quality and trustworthiness of our content and editorial processes
But the SEMALEAN data suggests that semaglutide does not inherently destroy muscle in the way some early headlines suggested, especially when patients maintain adequate protein and physical activity
Butsch, who has previously consulted for Novo Nordisk (maker of Wegovy) and Eli Lilly (maker of Zepbound), said he was already concerned about the ubiquity of compounded semaglutide and tirzepatide in recent years
It also attaches to the GLP-1 receptors in the brain and the gut to signal that you're full
GLP-1 RAs are designed to last much longer, from the time you take one dose until the time the next is due